-
公开(公告)号：KR101349083B1
公开(公告)日：2014-01-16
申请号：KR1020120020537
申请日：2012-02-28
Applicant: 한국식품연구원
CPC classification number: Y02A90/26
Abstract: 본 발명은 간 추출물에 존재하는 특정 대사체의 농도를 측정하여 노화 진단을 위한 정보를 제공하는 방법 및 진단용 키트에 관한 것이다. 본 발명에 따르면 간 추출물에 존재하는 특정 대사체의 농도 변화를 측정하여 노화의 진행 여부 및 노화와 관련된 질병을 진단할 수 있고, 나아가 노화와 연관된 질병의 치료에 활용할 수 있다.
-
公开(公告)号：KR1020130078326A
公开(公告)日：2013-07-10
申请号：KR1020110147201
申请日：2011-12-30
Applicant: 한국식품연구원
IPC: A61K31/353 , A61K9/08 , A61P17/00
Abstract: PURPOSE: A pharmaceutical composition containing auraptene as an active ingredient for promoting angiogenesis is provided to promote angiogenesis by auraptene, and to effectively regenerate tissues through skin flap regeneration, wound and burn healing, and artificial skin transplantation. CONSTITUTION: A pharmaceutical composition for promoting angiogenesis contains 1-10 micromole of auraptene as an active ingredient. Auraptene promotes tissue regeneration. The pharmaceutical composition is used for skin flap regeneration, wound and burn healing, artificial skin transplantation, or preparation of blood vessels for transplantation. A food composition for promoting angiogenesis contains auraptene as an active ingredient. Auraptene promotes angiogenesis. [Reference numerals] (AA) Control group; (BB) Auraptene 1μM; (CC) Auraptene 5μM; (DD) Auraptene 10μM; (EE) Auraptene 40μM
Abstract translation: 目的：提供含有紫罗烯作为促进血管发生的活性成分的药物组合物，用于促进紫罗烯烯的血管生成，并通过皮瓣再生，伤口和烧伤愈合以及人造皮肤移植有效地再生组织。 构成：用于促进血管发生的药物组合物含有1-10微摩尔的奥来哌啶作为活性成分。 Auraptene促进组织再生。 药物组合物用于皮瓣再生，伤口和烧伤愈合，人造皮肤移植或用于移植的血管制备。 用于促进血管生成的食品组合物含有作为活性成分的紫罗烯。 Auraptene促进血管生成。 （附图标记）（AA）对照组; （BB）Auraptene1μM; （CC）Auraptene5μM; （DD）Auraptene10μM; （EE）Auraptene40μM
-
公开(公告)号：KR1020120048205A
公开(公告)日：2012-05-15
申请号：KR1020100109716
申请日：2010-11-05
Applicant: 한국식품연구원
IPC: A61K31/198 , A61P3/04 , A61P3/06 , A61P3/10
Abstract: PURPOSE: A pharmaceutical composition and health food containing methylselenocystein is provided to prevent and treat obesity and lipid-related metabolic diseases. CONSTITUTION: A pharmaceutical composition for preventing and treating obesity and lipid-related metabolic diseases contains methylselenocysteine as an active ingredient. The composition is manufactured in the form of powder, granules, tablets, capsules, suspension, emulsion, syrup, oral formulation of aerosol, external use, suppository, or sterilized injection solution. A health food for preventing and relieving obesity and metabolic diseases contains methylselenocystein as an active ingredient. The health food is manufactured in the form of capsules, tablets, granules, powder, or beverage.
Abstract translation: 目的：提供含有甲基硒代半胱氨酸的药物组合物和保健食品，用于预防和治疗肥胖症和与脂质有关的代谢疾病。 构成：用于预防和治疗肥胖症和脂质相关代谢疾病的药物组合物含有甲基硒代半胱氨酸作为活性成分。 该组合物以粉末，颗粒，片剂，胶囊，悬浮液，乳剂，糖浆，气雾剂口服制剂，外用，栓剂或灭菌注射液的形式制备。 用于预防和缓解肥胖和代谢疾病的保健食品含有甲基硒代半胱氨酸作为活性成分。 保健食品以胶囊，片剂，颗粒，粉末或饮料的形式制造。
-
公开(公告)号：KR1020120004828A
公开(公告)日：2012-01-13
申请号：KR1020100065515
申请日：2010-07-07
Applicant: 한국식품연구원
IPC: A61K31/05 , A61K31/045 , A61P29/00
Abstract: PURPOSE: A 2,4 D-tertiary-butylphenol or salt thereof for anti-inflammation is provided to suppress iNOS expression and to prevent and treat inflammation. CONSTITUTION: An anti-inflammatory composition contains 2,4 D-tertiary-butylphenol or salt thereof as an active ingredient. A pharmaceutical composition for preventing and treating inflammation contains 2,4 D-tertiary phenol or pharmacologically acceptable salt thereof as an active ingredient. A food composition for preventing and treating inflammation contains 0.01-10 wt% of 2,4-D-tertiary-butylphenol or sitologically acceptable salt thereof as an active ingredient. The salt is acid addition salt.
Abstract translation: 目的：提供用于抗炎的2,4-二叔丁基苯酚或其盐以抑制iNOS表达并预防和治疗炎症。 构成：抗炎组合物含有2,4-二叔丁基苯酚或其盐作为活性成分。 用于预防和治疗炎症的药物组合物含有2,4-二叔酚或其药理学上可接受的盐作为活性成分。 用于预防和治疗炎症的食品组合物含有0.01-10重量％的2,4-D-叔丁基苯酚或其可以选择的盐作为活性成分。 盐是酸加成盐。
-
公开(公告)号：KR102085663B1
公开(公告)日：2020-03-09
申请号：KR1020190000216
申请日：2019-01-02
Applicant: 한국 한의학 연구원 , 한국식품연구원
IPC: C12Q1/6883
-
Patent Agency Ranking66.发明公开4-(4-하이드록시-4-메틸펜틸)-3-사이클로-헥센-1-카복스알데하이드를 포함하는 신생혈관형성 촉진용 조성물 有权4-4--4--3 --- 1-用于促进血管生成的组合物，包括4-4-羟基-4-甲基戊基-3-环己烯-1-甲醛
公开(公告)号：KR1020170025696A
公开(公告)日：2017-03-08
申请号：KR1020150122505
申请日：2015-08-31
Applicant: 한국식품연구원
IPC: A61K31/11 , A61K31/045 , A61K9/14 , A61K9/20 , A61K9/48
Abstract: 본발명은 4-(4-하이드록시-4-메틸펜틸)-3-사이클로-헥센-1-카복스알데하이드를포함하는신생혈관형성촉진용조성물에관한것으로, 본발명에따른조성물은후각수용체인 OR10J5가발현되는세포또는조직, 예를들어, 이에제한되는것은아니나, 심장대동맥, 관상동맥및 내피세포에서신생혈관생성을촉진하는효과가있다.
-
-
公开(公告)号：KR101655982B1
公开(公告)日：2016-09-08
申请号：KR1020140034101
申请日：2014-03-24
Applicant: 한국식품연구원
IPC: A61K36/70 , A61K36/28 , A61K36/66 , A61K36/48 , A61K36/12 , A61K36/75 , A61K36/58 , A61P3/10 , A61P3/04 , A61P25/00
Abstract: 본발명은부작용이적어안전하면서도장 내분비세포자극활성이뛰어난약학조성물또는식품조성물에관한것으로서, 삼잎국화추출물, 우산나물추출물, 고마리추출물, 매미나물추출물, 야관문추출물, 소국추출물, 도깨비고비추출물, 산초추출물, 참죽나무추출물및 큰여뀌추출물로이루어진군에서선택된어느하나이상을유효성분으로포함하는비만예방및 개선, 당뇨병예방및 개선, 심장질환개선, 소화장애및 흡수장애개선또는치료, 또는신경보호작용을위한약학조성물또는식품조성물에관한것이다. 본발명의조성물은 GLP-1, CCK 또는 5-HT의분비자극또는 hTGR5 활성화에영향을미칠수 있다.
-
公开(公告)号：KR1020160059028A
公开(公告)日：2016-05-26
申请号：KR1020140159911
申请日：2014-11-17
Applicant: 한국식품연구원
CPC classification number: A61K31/7048 , A23L33/10 , A23V2002/00 , A23V2200/00 , A61K9/0095 , A61K9/16 , A61K9/20 , A61K9/48
Abstract: 본발명은푸니칼라진(punicalagin)을유효성분으로함유하는전립선비대증의예방또는치료용약학적조성물, 식품조성물및 건강기능식품에관한것으로, 본발명에따른푸니칼라진은전립선무게감소효과가우수하므로, 이를유효성분으로함유하는전립선비대증의예방또는치료용약학적조성물, 식품조성물및 건강기능식품으로사용할수 있다.
Abstract translation: 本发明涉及一种用于预防或治疗良性前列腺增生的药物组合物，其包含作为活性成分的肾上腺素作为食物组合物，以及健康功能性食品。 根据本发明，防腐剂对减轻前列腺的重量具有优异的效果，可以用作预防或治疗良性前列腺增生的药物组合物，其包含与活性成分相同的食品组合物，和 健康功能食品。
-
公开(公告)号：KR101614144B1
公开(公告)日：2016-05-02
申请号：KR1020140165273
申请日：2014-11-25
Applicant: 한국식품연구원
IPC: A61K31/4525 , A61K31/36 , A61P11/02
CPC classification number: A61K31/4525 , A61K31/357 , A61K31/36 , A61K31/435
Abstract: 본발명은피페린또는이의염을유효성분으로후각과민증의예방및 치료용약학적조성물에관한것이다. 또한, 본발명은피페린또는이의염을유효성분으로함유하는후각과민증의예방및 완화를위한건강기능식품에관한것이다. 본발명의조성물은후각신호전달을억제함으로써후각과민증을억제하는우수한효과가있다.
Abstract translation: 本发明涉及一种用于预防和治疗高血糖的药物组合物，其包含胡椒碱或其盐作为活性成分。 此外，本发明涉及一种用于预防和缓解高血糖的健康功能性食品，其包含胡椒碱或其盐作为活性成分。 通过抑制嗅觉信号的输送，本发明的组合物具有优异的抑制高血压的效果。
-
-
-
-
-
-
-
-
-
Search Results
84
records
(took 0.053 seconds)
